Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

7TFP CDH1 reporter Citations (3)

Originally described in: Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability.
Pattabiraman DR, Bierie B, Kober KI, Thiru P, Krall JA, Zill C, Reinhardt F, Tam WL, Weinberg RA Science. 2016 Mar 4;351(6277):aad3680. doi: 10.1126/science.aad3680.
PubMed Journal

Articles Citing 7TFP CDH1 reporter

Articles
PLCepsilon regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1. Fan J, Fan Y, Wang X, Niu L, Duan L, Yang J, Li L, Gao Y, Wu X, Luo C. J Exp Clin Cancer Res. 2019 Aug 5;38(1):337. doi: 10.1186/s13046-019-1323-8. PubMed
Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis. Dong Y, Hu H, Zhang X, Zhang Y, Sun X, Wang H, Kan W, Tan MJ, Shi H, Zang Y, Li J. Signal Transduct Target Ther. 2023 Mar 6;8(1):95. doi: 10.1038/s41392-022-01302-6. PubMed
The study of a novel CDK8 inhibitor E966-0530-45418 that inhibits prostate cancer metastasis in vitro and in vivo. Ho TY, Sung TY, Pan SL, Huang WJ, Hsu KC, Hsu JY, Lin TE, Hsu CM, Yang CR. Biomed Pharmacother. 2023 Jun;162:114667. doi: 10.1016/j.biopha.2023.114667. Epub 2023 Apr 8. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.